Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937)

International Journal of Antimicrobial Agents

Volumn 27, Issue 4, 2006, Pages 316-324

  Mpiga, Philomene ^a   Ravaoarinoro, Madeleine ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Doxycycline; Erythromycin; Persistent infection; Tetracycline; Therapy failure

Indexed keywords

DOXYCYCLINE; ERYTHROMYCIN; MESSENGER RNA; RNA 16S; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CELL VIABILITY; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; OMP 1 GENE; PERSISTENT INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE;

EID: 33645980677     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.11.010     Document Type: Article

References (44)

1. Mabey D., and Fraser-Hurt N. Trachoma. BMJ 323 (2001) 218-221
2. Mabey D.C., Solomon A.W., and Foster A. Trachoma. Lancet 362 (2003) 223-229
3. Bjartling C., Osser S., and Persson K. The frequency of salpingitis and ectopic pregnancy as epidemiologic markers of Chlamydia trachomatis. Acta Obstet Gynecol Scand 79 (2000) 123-128
4. Toth M., Patton D.L., Campbell L.A., et al. Detection of chlamydial antigenic material in ovarian, prostatic, ectopic pregnancy and semen samples of culture-negative subjects. Am J Reprod Immunol 43 (2000) 218-222
5. Mabey D., and Peeling R.W. Lymphogranuloma venereum. Sex Transm Infect 78 (2002) 90-92
6. Cohen C.R., Plummer F.A., Mugo N., et al. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission?. AIDS 13 (1999) 327-332
7. Ho J.L., He S., Hu A., et al. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J Exp Med 181 (1995) 1493-1505
8. Silins I., Ryd W., Strand A., et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 116 (2005) 110-115
9. Smith J.S., Munoz N., Herrero R., et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185 (2002) 324-331
10. Scidmore M.A., Fischer E.R., and Hackstadt T. Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect Immun 71 (2003) 973-984
11. Wyrick P.B. Intracellular survival by Chlamydia. Cell Microbiol 2 (2000) 275-282
12. Beatty W.L., Belanger T.A., Desai A.A., et al. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun 62 (1994) 3705-3711
13. Beatty W.L., Byrne G.I., and Morrison R.P. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 90 (1993) 3998-4002
14. Beatty W.L., Byrne G.I., and Morrison R.P. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol 2 (1994) 94-98
15. Coles A.M., Reynolds D.J., Harper A., et al. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis?. FEMS Microbiol Lett 106 (1993) 193-200
16. Harper A., Pogson C.I., Jones M.L., et al. Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect Immun 68 (2000) 1457-1464
17. Raulston J.E. Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 65 (1997) 4539-4547
18. Shemer-Avni Y., Wallach D., and Sarov I. Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon. Infect Immun 57 (1989) 3484-3490
19. Wyrick P.B., and Knight S.T. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J Antimicrob Chemother 54 (2004) 79-85
20. Beatty W.L., Morrison R.P., and Byrne G.I. Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection. Infect Immun 62 (1994) 4059-4062
21. Brunham R.C., Maclean I.W., and Binns B. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 152 (1985) 1275-1282
22. Grayston J.T., and Wang S. New knowledge of chlamydiae and the diseases they cause. J Infect Dis 132 (1975) 87-105
23. Joyner J.L., Douglas Jr. J.M., and Foster M. Persistence of Chlamydia trachomatis infection detected by polymerase chain reaction in untreated patients. Sex Transm Dis 29 (2002) 196-200
24. Morre S.A., van den Brule A.J., Rozendaal L., et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 13 (2002) 12-18
25. Adimora A.A. Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. Clin Infect Dis 35 (2002) S183-S186
26. Guaschino S., and Ricci G. How, and how efficiently, can we treat Chlamydia trachomatis infections in women?. Best Pract Res Clin Obstet Gynaecol 16 (2002) 875-888
27. Xu F., Schillinger J.A., Markowitz L.E., et al. Repeat Chlamydia trachomatis infection in women: analysis through a surveillance case registry in Washington State, 1993-1998. Am J Epidemiol 152 (2000) 1164-1170
28. Whittington W.L., Kent C., Kissinger P., et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 28 (2001) 117-123
29. Selliah S., and Ravaoarinoro M. Pharmacokinetics of cationic liposome-encapsulated doxycycline in mice challenged with genital infection by Chlamydia trachomatis. Chemotherapy 50 (2004) 17-21
30. Sangare L., Morisset R., and Ravaoarinoro M. In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline. J Med Microbiol 48 (1999) 689-693
31. Sangare L., Morisset R., Gaboury L., et al. Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice. J Antimicrob Chemother 47 (2001) 323-331
32. Gerard H.C., Whittum-Hudson J.A., and Hudson A.P. Genes required for assembly and function of the protein synthetic system in Chlamydia trachomatis are expressed early in elementary to reticulate body transformation. Mol Gen Genet 255 (1997) 637-642
33. Gerard H.C., Branigan P.J., and Balsara G.R. Viability of Chlamydia trachomatis in fallopian tubes of patients with ectopic pregnancy. Fertil Steril 70 (1998) 945-948
34. Gerard H.C., Branigan P.J., Schumacher Jr. H.R., et al. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 25 (1998) 734-742
35. Bragina E.Y., Gomberg M.A., and Dmitriev G.A. Electron microscopic evidence of persistent chlamydial infection following treatment. J Eur Acad Dermatol Venereol 15 (2001) 405-409
36. Dean D., Suchland R.J., and Stamm W.E. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis 182 (2000) 909-916
37. Smith A., Munoz B., Hsieh Y.H., et al. OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women. Ophthalmic Epidemiol 8 (2001) 127-135
38. Dreses-Werringloer U., Padubrin I., and Jurgens-Saathoff B. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 44 (2000) 3288-3297
39. Dreses-Werringloer U., Padubrin I., Zeidler H., et al. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 45 (2001) 3001-3008
40. Hanada H., Ikeda-Dantsuji Y., Naito M., et al. Infection of human fibroblast-like synovial cells with Chlamydia trachomatis results in persistent infection and interleukin-6 production. Microb Pathog 34 (2003) 57-63
41. Rothfuchs A.G., Kreuger M.R., Wigzell H., et al. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma. J Immunol 172 (2004) 2407-2415
42. Ramsey K.H., Miranpuri G.S., Sigar I.M., et al. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun 69 (2001) 5131-5137
43. Ojcius D.M., Hellio R., and Dautry-Varsat A. Distribution of endosomal, lysosomal, and major histocompatibility complex markers in a monocytic cell line infected with Chlamydia psittaci. Infect Immun 65 (1997) 2437-2442
44. Beatty W.L., Morrison R.P., and Byrne G.I. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun 63 (1995) 199-205